Page last updated: 2024-08-23

4-ipomeanol and Glioma

4-ipomeanol has been researched along with Glioma in 1 studies

*Glioma: Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21) [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chi, DY; Jang, SJ; Kang, JH; Kim, SE; Kim, SJ; Lee, BC; Lee, TS; Moon, BS1

Other Studies

1 other study(ies) available for 4-ipomeanol and Glioma

ArticleYear
Synthesis and evaluation of a 18F-labeled 4-ipomeanol as an imaging agent for CYP4B1 gene prodrug activation therapy.
    Cancer biotherapy & radiopharmaceuticals, 2013, Volume: 28, Issue:8

    Topics: Animals; Aryl Hydrocarbon Hydroxylases; Drug Stability; Fluorine Radioisotopes; Glioma; Humans; Isotope Labeling; Prodrugs; Radiopharmaceuticals; Rats; Rats, Inbred F344; Terpenes; Transfection; Tumor Cells, Cultured

2013